These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
395 related articles for article (PubMed ID: 34711637)
1. Risks of and From SARS-CoV-2 Infection and COVID-19 in People With Diabetes: A Systematic Review of Reviews. Hartmann-Boyce J; Rees K; Perring JC; Kerneis SA; Morris EM; Goyder C; Otunla AA; James OA; Syam NR; Seidu S; Khunti K Diabetes Care; 2021 Dec; 44(12):2790-2811. PubMed ID: 34711637 [TBL] [Abstract][Full Text] [Related]
2. Care bundles for improving outcomes in patients with COVID-19 or related conditions in intensive care - a rapid scoping review. Smith V; Devane D; Nichol A; Roche D Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013819. PubMed ID: 33348427 [TBL] [Abstract][Full Text] [Related]
3. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a rapid review. Valk SJ; Piechotta V; Chai KL; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2020 May; 5(5):CD013600. PubMed ID: 32406927 [TBL] [Abstract][Full Text] [Related]
4. Universal screening for SARS-CoV-2 infection: a rapid review. Viswanathan M; Kahwati L; Jahn B; Giger K; Dobrescu AI; Hill C; Klerings I; Meixner J; Persad E; Teufer B; Gartlehner G Cochrane Database Syst Rev; 2020 Sep; 9(9):CD013718. PubMed ID: 33502003 [TBL] [Abstract][Full Text] [Related]
5. Antibody tests for identification of current and past infection with SARS-CoV-2. Deeks JJ; Dinnes J; Takwoingi Y; Davenport C; Spijker R; Taylor-Phillips S; Adriano A; Beese S; Dretzke J; Ferrante di Ruffano L; Harris IM; Price MJ; Dittrich S; Emperador D; Hooft L; Leeflang MM; Van den Bruel A; Cochrane Database Syst Rev; 2020 Jun; 6(6):CD013652. PubMed ID: 32584464 [TBL] [Abstract][Full Text] [Related]
6. Measures implemented in the school setting to contain the COVID-19 pandemic. Krishnaratne S; Littlecott H; Sell K; Burns J; Rabe JE; Stratil JM; Litwin T; Kreutz C; Coenen M; Geffert K; Boger AH; Movsisyan A; Kratzer S; Klinger C; Wabnitz K; Strahwald B; Verboom B; Rehfuess E; Biallas RL; Jung-Sievers C; Voss S; Pfadenhauer LM Cochrane Database Syst Rev; 2022 Jan; 1(1):CD015029. PubMed ID: 35037252 [TBL] [Abstract][Full Text] [Related]
7. Travel-related control measures to contain the COVID-19 pandemic: a rapid review. Burns J; Movsisyan A; Stratil JM; Coenen M; Emmert-Fees KM; Geffert K; Hoffmann S; Horstick O; Laxy M; Pfadenhauer LM; von Philipsborn P; Sell K; Voss S; Rehfuess E Cochrane Database Syst Rev; 2020 Oct; 10():CD013717. PubMed ID: 33502002 [TBL] [Abstract][Full Text] [Related]
8. Chloroquine or hydroxychloroquine for prevention and treatment of COVID-19. Singh B; Ryan H; Kredo T; Chaplin M; Fletcher T Cochrane Database Syst Rev; 2021 Feb; 2(2):CD013587. PubMed ID: 33624299 [TBL] [Abstract][Full Text] [Related]
9. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas. Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557 [TBL] [Abstract][Full Text] [Related]
10. Convalescent plasma for people with COVID-19: a living systematic review. Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N Cochrane Database Syst Rev; 2023 May; 5(5):CD013600. PubMed ID: 37162745 [TBL] [Abstract][Full Text] [Related]
11. Measures implemented in the school setting to contain the COVID-19 pandemic: a scoping review. Krishnaratne S; Pfadenhauer LM; Coenen M; Geffert K; Jung-Sievers C; Klinger C; Kratzer S; Littlecott H; Movsisyan A; Rabe JE; Rehfuess E; Sell K; Strahwald B; Stratil JM; Voss S; Wabnitz K; Burns J Cochrane Database Syst Rev; 2020 Dec; 12(12):CD013812. PubMed ID: 33331665 [TBL] [Abstract][Full Text] [Related]
13. Convalescent plasma for people with COVID-19: a living systematic review. Iannizzi C; Chai KL; Piechotta V; Valk SJ; Kimber C; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Jindal A; Cryns N; Estcourt LJ; Kreuzberger N; Skoetz N Cochrane Database Syst Rev; 2023 Feb; 2(2):CD013600. PubMed ID: 36734509 [TBL] [Abstract][Full Text] [Related]
14. Risks and Impact of Angiotensin-Converting Enzyme Inhibitors or Angiotensin-Receptor Blockers on SARS-CoV-2 Infection in Adults: A Living Systematic Review. Mackey K; King VJ; Gurley S; Kiefer M; Liederbauer E; Vela K; Sonnen P; Kansagara D Ann Intern Med; 2020 Aug; 173(3):195-203. PubMed ID: 32422062 [TBL] [Abstract][Full Text] [Related]
15. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review. Piechotta V; Iannizzi C; Chai KL; Valk SJ; Kimber C; Dorando E; Monsef I; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2021 May; 5(5):CD013600. PubMed ID: 34013969 [TBL] [Abstract][Full Text] [Related]
16. SARS-CoV-2-neutralising monoclonal antibodies for treatment of COVID-19. Kreuzberger N; Hirsch C; Chai KL; Tomlinson E; Khosravi Z; Popp M; Neidhardt M; Piechotta V; Salomon S; Valk SJ; Monsef I; Schmaderer C; Wood EM; So-Osman C; Roberts DJ; McQuilten Z; Estcourt LJ; Skoetz N Cochrane Database Syst Rev; 2021 Sep; 9(9):CD013825. PubMed ID: 34473343 [TBL] [Abstract][Full Text] [Related]